Atea Pharmaceuticals, Inc.
AVIR
$3.66
$0.133.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.29% | 45.75% | 14.35% | 6.01% | -43.78% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -65.49% | -42.72% | 48.28% | 18.62% | 12.01% |
| Change in Net Operating Assets | 107.33% | -111.39% | -190.74% | -121.08% | -447.56% |
| Cash from Operations | 22.11% | 23.33% | -39.22% | -30.95% | -161.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -87.74% | 50.71% | -112.13% | -108.52% | 167.77% |
| Cash from Investing | -87.74% | 50.71% | -112.13% | -108.52% | 167.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -8.00% | -- | 27.17% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -331.33% | -- | 27.17% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -138.40% | 220.11% | -668.76% | -90.67% | 170.93% |